{"id":3296,"date":"2026-06-07T18:02:06","date_gmt":"2026-06-07T16:02:06","guid":{"rendered":"https:\/\/arevipharma.com\/pharmaceutical-active-ingredients\/"},"modified":"2026-09-17T15:07:54","modified_gmt":"2026-09-17T13:07:54","slug":"active-pharmaceutical-ingredients","status":"publish","type":"page","link":"https:\/\/arevipharma.com\/en\/services\/active-pharmaceutical-ingredients\/","title":{"rendered":"API Portfolio"},"content":{"rendered":"

API Portfolio<\/p>\n<\/div>

Our APIs are a 100% perfect fit for your needs<\/h3><\/div>

Arevipharma offers a broad range of synthetic, generic active pharmaceutical ingredients in various volume, indication and substance classes. All active pharmaceutical ingredients are produced at the Radebeul site under cGMP conditions and are already registered in many global pharmaceutical markets. In coordination with our customers, we also regularly, quickly and reliably tackle approval projects in countries that are additionally required for their marketing strategy. <\/p>\n

Narcotics represent an important part of our portfolio of active ingredients. Arevipharma can handle all classes of these active ingredients without any volume restrictions. This makes us one of the largest manufacturers of narcotics in the world.<\/p>\n<\/div>

Download Product Portfolio PDF<\/span><\/a><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
\n
\n

APIs<\/strong><\/h3>\n
Controlled Substances<\/strong><\/h5>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product<\/th>\nIndication<\/th>\nRegulatory Documentation<\/th>\n<\/tr>\n<\/thead>\n
Amfepramone HCl<\/td>\nAppetite depressant<\/td>\nUS-DMF, ASMF<\/td>\n<\/tr>\n
Arketamine HCl*<\/td>\nAntidepressant<\/td>\nASMF<\/td>\n<\/tr>\n
Buprenorphine<\/td>\nAnalgesic, OUD<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Buprenorphine HCl<\/td>\nAnalgesic<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Esketamine HCl*<\/td>\nAnalgesic, Antidepressant<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Fentanyl<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n
Fentanyl Citrate<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n
Ketamine HCl*<\/td>\nAnalgesic<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Remifentanil HCl<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n
Tilidine HCl HH<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*No controlled substance in several countries (e.g. Germany)<\/p>\n<\/div>\n<\/div><\/div>

\n
\n
Other APIs<\/strong><\/h5>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product<\/th>\nIndication<\/th>\nRegulatory Documentation<\/th>\n<\/tr>\n<\/thead>\n
Amiodarone HCl<\/td>\nAntiarrhythmic<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Bisoprolol Fumarate<\/td>\nAntihypertensive, beta-blocker<\/td>\nCEP, US-DMF, J-DMF, ASMF<\/td>\n<\/tr>\n
Cafedrine HCl<\/td>\nCardiac Stimulant<\/td>\nASMF<\/td>\n<\/tr>\n
Cannabidiol<\/td>\nVarious<\/td>\nASMF<\/td>\n<\/tr>\n
Carbamazepine<\/td>\nAnticonvulsant<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Cetirizine 2HCl<\/td>\nAntihistamines<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Dimethyl fumarates<\/td>\nPsoriasis, multiple sclerosis<\/td>\nUS-DMF, ASMF<\/td>\n<\/tr>\n
Doxapram HCl<\/td>\nAnaleptic<\/td>\nCEP, US-DMF, J-DMF<\/td>\n<\/tr>\n
Ebastine<\/td>\nAntihistamines<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Naloxone HCl DH<\/td>\nOpioid Antagonist<\/td>\nCEP submitted, US-DMF to be filed, ASMF<\/td>\n<\/tr>\n
Naltrexone HCl<\/td>\nOUD, AUD<\/td>\nCEP submitted, US-DMF to be filed, ASMF<\/td>\n<\/tr>\n
Phenprocoumon<\/td>\nAnticoagulant<\/td>\nASMF<\/td>\n<\/tr>\n
Phytosterol<\/td>\nUrological diseases<\/td>\nASMF<\/td>\n<\/tr>\n
Pyridostigmine Bromide<\/td>\nParasympathomimetic<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Rivastigmine<\/td>\nAlzheimer\u2019s disease<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Sotalol HCl<\/td>\nAntiarrhythmic, beta blocker<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Sultiame<\/td>\nAnticonvulsant<\/td>\nASMF<\/td>\n<\/tr>\n
Theodrenaline HCl<\/td>\nCardiac Stimulant<\/td>\nASMF<\/td>\n<\/tr>\n
Torasemide<\/td>\ndiuretic<\/td>\nCEP, ASMF, J-DMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div><\/div>
\n
\n
R&D Products<\/strong><\/h5>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product<\/th>\nIndication<\/th>\nRegulatory Documentation<\/th>\n<\/tr>\n<\/thead>\n
Oxymorphone<\/td>\nAnalgesic, Intermediate<\/td>\nPilot scale<\/td>\n<\/tr>\n
Folinic Acid (Calcium Folinate, Leucovorin)<\/td>\nRescue Agent<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Hydromorphone HCl<\/td>\nAnalgesic<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Tirbanibulin<\/td>\nKeratosis<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Nalbuphine HCl<\/td>\nAnalgesic, partial antagonist<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Nalmefene HCl<\/td>\nOpioid Antagonist<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Oxycodone HCl<\/td>\nAnalgesic, Intermediate<\/td>\n Validation 2027<\/td>\n<\/tr>\n
Rivastigmine Tartrate<\/td>\nAnalgesic, Intermediate<\/td>\n Validation 2027<\/td>\n<\/tr>\n
Alfentanil, Sufentanil<\/td>\nAnalgesic<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Naloxegol<\/td>\nOpioid Antagonist<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Samidorphan<\/td>\nOpioid Antagonist<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Rotigotine<\/td>\nParkinson\u00b4s disease<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Droperidol<\/td>\nAntiemetic<\/td>\nUnder Evaluation<\/td>\n<\/tr>\n
Remimazolam<\/td>\nAnalgesic<\/td>\nUnder Evaluation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div><\/div><\/div><\/div>

Wir freuen uns auf Ihre Anfrage.<\/p><\/h3><\/div>

<\/i>CDMO<\/span><\/a><\/div>
<\/i>Sales<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3311,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-3296","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/comments?post=3296"}],"version-history":[{"count":9,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3296\/revisions"}],"predecessor-version":[{"id":4235,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3296\/revisions\/4235"}],"up":[{"embeddable":true,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3311"}],"wp:attachment":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/media?parent=3296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}